KYMERA THERAPEUTICS INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About KYMR
Kymera Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. The Company's targeted protein degradation (TPD) platform, which it refers to as Pegasus, allows it to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. It utilized its Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and it continues to apply its platform’s capabilities to additional therapeutic areas. Its clinical stage programs are IRAK4, STAT3, and MDM2, which each address high impact targets within biologically proven pathways, providing the opportunity to treat a range of immuno-inflammatory diseases, hematologic malignancies, and/or solid tumors.
Find out what a historical investment in KYMERA THERAPEUTICS INC would be worth today using our KYMR stock calculator.
$3.05B
-
0.00%
462
$47.75
$45.72
$0.00
$53.27
$19.45
Ready to start your investing journey with Stake?
Open an accountKYMR FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KYMR
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KYMR
on Stake
Buy KYMR from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of KYMR from only US$10 with fractional shares
